Nicotinamide phosphoribosyltransferase (NAMPT), which is responsible for biosynthesis of nicotinamideadenine dinucleotide (NAD), has a regulatory role in cellular metabolism and thus, might be implicated in non-alcoholicfatty liver disease (NAFLD). This evidence concerns the gene NAMPT and metabolic dysfunction-associated steatotic liver disease.